BI-0474
IP KRASG12Ci related to oral candidate BI 1823911 TGI in NCI-H358 cancer xenograft mouse model from 13k cmpd. HSQC-based screen and SBDD J. Med. Chem. Boehringer Ingelheim, Vienna, AT
Molecules of the Month - October 2022
5 minute read
Nov. 28, 2022
BI-0474: A Covalent KRAS(G12C) Inhibitor from a Reversible Fragment